Our top pick for
CBM Bancorp, Inc is a banks-regional business based in the US. CBM Bancorp shares (CBMB) are listed on the NASDAQ and all prices are listed in US Dollars. CBM Bancorp employs 44 staff and has a trailing 12-month revenue of around USD$8.2 million.
|52-week range||USD$10.1368 - USD$15.05|
|50-day moving average||USD$14.0968|
|200-day moving average||USD$13.0918|
|Wall St. target price||N/A|
|Dividend yield||N/A (4.05%)|
|Earnings per share (TTM)||USD$0.189|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing CBM Bancorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CBM Bancorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CBM Bancorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 79x. In other words, CBM Bancorp shares trade at around 79x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
|Revenue TTM||USD$8.2 million|
|Operating margin TTM||15.03%|
|Gross profit TTM||USD$8.1 million|
|Return on assets TTM||0.32%|
|Return on equity TTM||1.26%|
|Market capitalisation||USD$55.3 million|
TTM: trailing 12 months
There are currently 288 CBM Bancorp shares held short by investors – that's known as CBM Bancorp's "short interest". This figure is 52.8% down from 610 last month.
There are a few different ways that this level of interest in shorting CBM Bancorp shares can be evaluated.
CBM Bancorp's "short interest ratio" (SIR) is the quantity of CBM Bancorp shares currently shorted divided by the average quantity of CBM Bancorp shares traded daily (recently around 3600). CBM Bancorp's SIR currently stands at 0.08. In other words for every 100,000 CBM Bancorp shares traded daily on the market, roughly 80 shares are currently held short.
However CBM Bancorp's short interest can also be evaluated against the total number of CBM Bancorp shares, or, against the total number of tradable CBM Bancorp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CBM Bancorp's short interest could be expressed as 0% of the outstanding shares (for every 100,000 CBM Bancorp shares in existence, roughly 0 shares are currently held short) or 0.0001% of the tradable shares (for every 100,000 tradable CBM Bancorp shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CBM Bancorp.
Find out more about how you can short CBM Bancorp stock.
Dividend payout ratio: 560.54% of net profits
Recently CBM Bancorp has paid out, on average, around 560.54% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.05% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CBM Bancorp shareholders could enjoy a 4.05% return on their shares, in the form of dividend payments. In CBM Bancorp's case, that would currently equate to about $N/A per share.
CBM Bancorp's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
CBM Bancorp's most recent dividend payout was on 19 March 2021.
Over the last 12 months, CBM Bancorp's shares have ranged in value from as little as $10.1368 up to $15.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CBM Bancorp's is 0.3358. This would suggest that CBM Bancorp's shares are less volatile than average (for this exchange).
CBM Bancorp, Inc. operates as a bank holding company for Chesapeake Bank of Maryland. Its deposit products include non-interest bearing and interest-bearing demand deposits, time deposits, money market deposits, and certificates of deposit, as well as savings and individual retirement accounts. The company's loan portfolio comprises one-to four-family residential real estate loans, nonresidential real estate loans, construction and land development loans, home equity loans and lines of credit, commercial business loans, and consumer loans. It also invests in various investment securities. The company operates through a main office located in Baltimore County, Maryland; and three branch offices located in Arbutus, Bel Air, and Pasadena, Maryland. CBM Bancorp, Inc. was founded in 1913 and is headquartered in Baltimore, Maryland.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.